Emerging Infectious Diseases Are Virulent Viruses-Are We Prepared? An Overview

Would global warming bring an increase of invertebrate-associated cutaneous invasive fungal infections?

Invasive mold-associated cutaneous disease is a rare but potentially catastrophic consequence of trauma. However, invertebrate bites are not well recognized as a mechanism for the inoculation of fungi into subcutaneous tissue that can also result in severe infections. Invertebrates often carry fungi with human pathogenic potential as part of their microbiome, and bites break the skin, providing a conduit for them to penetrate subcutaneous tissues where the establishment of infection can produce serious skin and soft tissue fungal diseases. In this essay, we review the existing data for invertebrate bite-associated cutaneous invasive fungal infections (IBA-cIFIs) and consider the potential consequences of global warming on their epidemiology. Climate changes will be associated with changes in the range of invertebrates and adaptation of their associated microbes to warmer temperatures. Fungal adaptation to higher temperatures can defeat the mammalian protective barrier and be associated with both more and different IBA-cIFIs.

Designing, Implementing and Optimising a Capacity‑Building Model for Infectious Disease Modelling in India

Background: Mathematical models are not integrated into the policy‑making process in low‑ and middle‑income countries, including India, primarily due to limited capacity in building mathematical models, lack of trust in the model findings and the reluctance of policy‑makers to apply the model findings to formulate policies. There is a perceived need to create a critical mass of trained infectious disease experts and modelers within the public health and clinical domain. Thus, with the support of the Department of Health Research (DHR), we developed a 3‑month post‑graduate (PG) certificate course on infectious disease modelling, the first of such a course in India. The first cycle of the course was delivered during July to September 2024, which produced the first cohort of 20 infectious disease modellers in the country. Methods: This paper describes the structure, content and key components of the first course along with the experiences, strengths, challenges and way forward from the participants' perspective using a mixed methods approach. Findings: Most of the participants felt that the learning objectives were clear (n = 18, 90%), course content was well organised and delivered (n = 19, 95%) and the course structure allowed all participants to fully participate (n = 19, 95%) in the learning process. The strengths of the course were: hybrid mode of delivery, well‑designed course content, theory lectures followed by practical sessions, regular trainer-trainee communication, interactive discussion forums and the 3‑day contact workshop. The key challenges were non‑availability of recorded videos, evening timings of the sessions and difficulty of some topics. Conclusions: The challenges and recommendations will feed into the subsequent course cycles. Future courses are planned to be hosted on an online platform to facilitate participant completion of the course at their own pace. More collaboration with various stakeholders, nationally and internationally, will be sought to improve the content, delivery and robustness of the program.

Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses

Single-dose, immunogenic DNA (iDNA) vaccines coding for whole live-attenuated viruses are reviewed. This platform, sometimes called immunization DNA, has been used for vaccine development for flavi- and alphaviruses. An iDNA vaccine uses plasmid DNA to launch live-attenuated virus vaccines in vitro or in vivo. When iDNA is injected into mammalian cells in vitro or in vivo, the RNA genome of an attenuated virus is transcribed, which starts replication of a defined, live-attenuated vaccine virus in cell culture or the cells of a vaccine recipient. In the latter case, an immune response to the live virus vaccine is elicited, which protects against the pathogenic virus. Unlike other nucleic acid vaccines, such as mRNA and standard DNA vaccines, iDNA vaccines elicit protection with a single dose, thus providing major improvement to epidemic preparedness. Still, iDNA vaccines retain the advantages of other nucleic acid vaccines. In summary, the iDNA platform combines the advantages of reverse genetics and DNA immunization with the high immunogenicity of live-attenuated vaccines, resulting in enhanced safety and immunogenicity. This vaccine platform has expanded the field of genetic DNA and RNA vaccines with a novel type of immunogenic DNA vaccines that encode entire live-attenuated viruses.

The health of mankind and the health of the planet in a historical-ethical perspective: an inseparable relationship and a single destiny

Recent years have seen increasingly severe natural disasters, the consequences of which have been catastrophic. Clearly, our global environment is undergoing major changes. The climate is becoming deranged and pollution on a global scale afflicts air, water, and land. We are faced with an unprecedented shortage of cultivable land and fresh water for drinking, irrigation, and livestock farming, while our marine systems are breaking down. These environmental changes have a very high anthropogenic component; they are induced by human activities that are potentially dangerous for both the environment and human life. Moreover, not only do they have an enormous impact on the environments in which we live and on our way of life, they also have harmful effects on our health. Indeed, we must understand that our body - as Hippocrates explained long ago - is a system that constantly interacts with the surrounding environment.